NJ-ADVA
14.6.2022 09:02:09 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that Edge, a regional research and education (R&E) network based in New Jersey, has expanded its deployment of the ADVA ALM fiber monitoring solution to improve real-time service performance and reduce operating costs. The in-service assurance technology enables Edge to rapidly detect and locate faults in its optical transport infrastructure throughout New York, New Jersey and Pennsylvania. With more complete network visibility, Edge can respond in an instant to fiber issues and fix problems before services are affected. The ability to immediately identify areas of concern and precisely target maintenance efforts also helps reduce truck rolls and improves cost-efficiency.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220613005463/en/
“As the Edge network and member base expands, we continuously strive to enhance our reliability and client experience. To do so, Edge has relied on ADVA technology for years and we count on leveraging their continued innovation to benefit our members. ADVA’s ALM assurance solution delivers real-time info on the quality of our fiber. It tells us exactly where repairs are needed, and that has proven to be a big help in terms of time and cost savings. In the past, we might know there was a problem causing intermittent disruption somewhere between New York and Philadelphia, for example. It could take days to find using traditional manual OTDR testing. Now we can react quickly and accurately, and there’s no more time wasted on site visits,” said a spokesperson for Edge. “The ALM lets us troubleshoot issues before they impact end users and deliver even more robust and efficient services, helping our customers advance research, education and economic development across the region.”
The ADVA ALM maximizes resource efficiency by providing comprehensive fiber health assurance. It now instantly alerts Edge to any fiber breaks or abnormal attenuation. The solution is also helping bolster network security by notifying maintenance teams of tapping attempts. The non-intrusive service-agnostic device identifies the exact geographic location of events through an intuitive graphical user interface. Featuring fanless operation and low-power consumption, the ultra-compact ALM enhances operational efficiency and sustainability across Edge’s infrastructure.
“The Edge network is a vital resource for the scientists, educators and healthcare providers they serve. We’re proud to support its team as they deliver even more to help organizations digitize their operations and achieve their strategic goals,” commented John Scherzinger, SVP of sales, Americas at ADVA. “Our ALM solution provides Edge with an intricate understanding of its optical fiber infrastructure. The tiny device has already had a big impact, helping the service provider diagnose and remedy issues while making maintenance easier and more environmentally friendly.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com
.
About Edge
Founded in 2000, Edge, a 501(c)(3) nonprofit corporation, serves as a purpose-built research and education wide area network and technology solutions partner. Edge connects members with affordable, easy access to high-performance optical networking, commodity Internet and Internet2 services, and a variety of technology-powered products, solutions, and services. The Edge member consortium consists of colleges and universities, K-12 schools and districts, government entities, healthcare networks, and businesses spread throughout the continental US. The group is governed by the New Jersey Presidents’ Council with offices in Newark, Princeton, and Wall Township, NJ. For more information, please visit: www.njedge.net
.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220613005463/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
